| Data | Hora | Fonte | Título | Código | Companhia |
| 03/08/2012 | 10:47 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 03/08/2012 | 09:52 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 03/08/2012 | 04:00 | Dow Jones News | GlaxoSmithKline Completes Acquisition of Human Genome Sciences | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 01/08/2012 | 18:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 01/08/2012 | 18:23 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 01/08/2012 | 15:24 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 01/08/2012 | 13:55 | Zacks | Loss at HGSI Wider Than Expected - Analyst Blog | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 31/07/2012 | 16:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 30/07/2012 | 10:06 | Dow Jones News | GlaxoSmithKline Gets 79% Tenders for Human Genome Sciences Offer | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 26/07/2012 | 17:22 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 26/07/2012 | 16:49 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 26/07/2012 | 12:46 | PR Newswire (US) | Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc. | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 26/07/2012 | 06:45 | Zacks | Glaxo Misses, Guidance Lowered - Analyst Blog | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 20/07/2012 | 10:32 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 19/07/2012 | 20:36 | Business Wire | Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breache... | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 19/07/2012 | 14:44 | Zacks | Glaxo to Increase Stake in Amicus - Analyst Blog | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 22:00 | PR Newswire (US) | Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc. | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 18:10 | Edgar (US Regulatory) | Amended Securities Registration (section 12(b)) (8-A12B/A) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 16:05 | Business Wire | Ryan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc. | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 16:05 | Business Wire | Human Genome Sciences Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow &... | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 15:10 | Zacks | TPG to Acquire Par Pharma for $1.9B - Analyst Blog | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 13:22 | Business Wire | Robbins Umeda LLP Announces an Investigation of Human Genome Sciences, Inc. | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 13:16 | Marketwired | Traders: Most Active Stocks: (OTCBB: CTDT), (NASDAQ: HGSI), (NASDAQ: AAPL), (NASDAQ: MAT) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 13:12 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 13:12 | Zacks | HGSI Accepts Glaxo's $14.25 Bid - Analyst Blog | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 17/07/2012 | 11:53 | Business Wire | Human Genome Sciences Shareholder Alert: The Briscoe Law Firm & Powers Taylor, LLP Investigate Sale of Human Genome Sciences ... | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 16/07/2012 | 18:30 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 16/07/2012 | 13:18 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Human ... | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 16/07/2012 | 10:15 | Business Wire | GSK to acquire Human Genome Sciences for US$14.25 per share in cash | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |
| 15/07/2012 | 20:10 | Dow Jones News | Glaxo Eyes Human Genome Sciences for $2.6 Billion | NASDAQ:HGSI | Human Genome Sciences, Inc. (MM) |